Multiple sclerosis
Research
The Florey has two laboratories conducting multiple sclerosis research:
- Multiple Sclerosis Laboratory led by Prof Trevor Kilpatrick
- Neurogenetics Laboratory led by Dr Justin Rubio
Media Releases
Media Releases about the Florey’s multiple sclerosis research are available in the Media Centre.
Links
- Society for Neuroscience - advancing the understanding of the brain and nervous system
- Better Health Channel - health and medical information quality assured by the Victorian Government
- HealthInsite - an Australian Government Initiative
Australian Statistics
- 1 in 1300 Australians has MS.
- There are around 15,000 people with MS in Australia.
- Tasmania has a higher incidence of MS than mainland Australia.
- MS is the most common cause of neurological disability for Australian men and women between the ages of 15 and 55.
- Around 10% of MS patients have difficulty either holding a book or newspaper, have blurred vision, or other disability.
- According to the World Health Organization, MS affects around 2.5 million people worldwide and is the most prevalent inflammatory demyelinating disease of the central nervous system in young adults.
MRI scan
The Brain
Relaxin
Led by Professor Geoffrey W. Tregear, the Relaxin Laboratory centres its main research on peptide ligand and protein receptor chemistry and biological function.